OcuTerra Therapeutics
Other - Boston, MA, US
OcuTerra Therapeutics Employees
David Tanzer
Chief Medical Officer | Executive Vice President - Clinical and Medical Affairs
OcuTerra Therapeutics Senior Management
OcuTerra Therapeutics Details
Non-Invasive, Transformational Approach to Treating Retinal Disease.OcuTerra is developing a novel eye drop, OTT166, designed to treat diabetic eye disease. This first-in-class, highly disruptive treatment has the potential to treat diabetic eye disease earlier and more efficiently, with established clinical data showing safety and demonstrating biological activity
Website:
ocuterratx.com
Employees:
5 - 9
HQ:
N/A
Location:
Boston, MA, US
Revenue:
Not Available
OcuTerra Therapeutics Technologies
Email Providers
Mimecast
Fonts
Typekit
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework